$331.14
0.48% today
NYSE, Dec 24, 06:16 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$329.57
+9.78 3.06% 1M
-1.43 0.43% 6M
-22.55 6.40% YTD
-25.36 7.15% 1Y
-130.27 28.33% 3Y
+178.36 117.96% 5Y
+275.99 515.10% 10Y
NYSE, Closing price Mon, Dec 23 2024
-1.83 0.55%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Market capitalization $23.87b
Enterprise Value $23.69b
P/E (TTM) P/E ratio 48.89
EV/FCF (TTM) EV/FCF 73.65
EV/Sales (TTM) EV/Sales 8.23
P/S ratio (TTM) P/S ratio 8.30
P/B ratio (TTM) P/B ratio 8.68
Dividend yield 0.24%
Last dividend (FY23) $0.78
Revenue growth (TTM) Revenue growth -1.70%
Revenue (TTM) Revenue $2.88b
EBIT (operating result TTM) EBIT $596.20m
Free Cash Flow (TTM) Free Cash Flow $321.60m
Cash position $490.90m
EPS (TTM) EPS $6.74
P/E forward 50.42
P/S forward 8.27
EV/Sales forward 8.21
Short interest 2.11%
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

7x Buy
54%
6x Hold
46%

Analyst Opinions

13 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
54%
Hold
46%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,876 2,876
2% 2%
100%
- Direct Costs 1,870 1,870
3% 3%
65%
1,007 1,007
10% 10%
35%
- Selling and Administrative Expenses 191 191
9% 9%
7%
- Research and Development Expense 69 69
5% 5%
2%
747 747
11% 11%
26%
- Depreciation and Amortization 151 151
14% 14%
5%
EBIT (Operating Income) EBIT 596 596
16% 16%
21%
Net Profit 500 500
11% 11%
17%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Neutral
PRNewsWire
13 days ago
EXTON, Pa. , Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms.
Positive
Seeking Alpha
16 days ago
Over the next 25 years, $124 trillion in inheritances will be transferred, reshaping wealth distribution and offering new investment opportunities for younger generations. Three dividend growth companies on my watch list have impressive potential, enjoying strong secular growth. While these companies may not be “mainstream,” their solid business models and growth prospects make them excellent p...
Positive
Seeking Alpha
about 2 months ago
This week, 17 companies with an average dividend increase of 8.3% are highlighted, emphasizing consistent dividend growth and outperforming benchmarks. My investment strategy focuses on buying, holding, and adding companies with consistent dividend increases and superior performance compared to benchmarks. The list is created using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ,...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today